As I speculated a couple of weeks back, mergers and acquisitions have started to pick up in the biotech sectorIt looks like a bidding war has started for mid-cap Medivation (MDVN), which already seen its stock price double and could eventually fetch more than $10 billion from the victorious suitorLast week AbbVie (ABBV) acquired a privately held s...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.